Inicio › Colitis ulcerativa › Kentucky
Ensayos clínicos de Colitis ulcerativa en Kentucky
12 estudios sobre Colitis ulcerativa buscan participantes en Kentucky.
Ciudades en Kentucky
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, Louisville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Health Partners, Louisville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, Louisville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07186101A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Tri-State Gastroenterology Assoc, Crestview Hills
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577856Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Louisville
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 oct 2026 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-State Gastroenterology Associates, Crestview Hills
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284144, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 030, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07012395Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Louisville, Louisville
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 23 oct 2026 · NCT05987852An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kentucky Hospital/UK Albert B. Chandler Hospital - Site Number: 8400058, Lexington
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07184996A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058, Lexington
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07185009De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.